RCM
NVS icon

RNC Capital Management’s Novartis NVS Stock Holding History

RNC Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$668K Sell
4,261
-236
-5% -$35.4K 0.03% 125
2026
Q1 		$687K Sell
4,497
-101
-2% -$15.5K 0.03% 119
2025
Q4 		$634K Buy
4,598
+162
+4% +$21.2K 0.03% 122
2025
Q3 		$569K Buy
4,436
+310
+8% +$37.8K 0.03% 125
2025
Q2 		$499K Buy
4,126
+450
+12% +$50.7K 0.02% 131
2025
Q1 		$410K Buy
3,676
+131
+4% +$13.9K 0.02% 124
2024
Q4 		$345K Sell
3,545
-137
-4% -$14.6K 0.02% 130
2024
Q3 		$392K Hold
3,682
– – 0.02% 120
2024
Q2 		$392K Buy
3,682
+16
+0.4% +$1.61K 0.02% 120
2024
Q1 		$355K Sell
3,666
-141
-4% -$14.5K 0.02% 123
2023
Q4 		$384K Buy
3,807
+560
+17% +$54.1K 0.02% 115
2023
Q3 		$331K Sell
3,247
-279
-8% -$28.3K 0.02% 123
2023
Q2 		$356K Sell
3,526
-181
-5% -$18.1K 0.02% 139
2023
Q1 		$341K Buy
3,707
+128
+4% +$11.2K 0.02% 147
2022
Q4 		$325K Sell
3,579
-495
-12% -$41.7K 0.02% 144
2022
Q3 		$310K Sell
4,074
-81
-2% -$6.71K 0.02% 138
2022
Q2 		$351K Buy
4,155
+89
+2% +$7.81K 0.02% 142
2022
Q1 		$357K Buy
4,066
+140
+4% +$12.1K 0.02% 147
2021
Q4 		$343K Buy
3,926
+1,235
+46% +$103K 0.02% 148
2021
Q3 		$220K Buy
2,691
+375
+16% +$33.7K 0.01% 169
2021
Q2 		$211K Buy
+2,316
New +$206K 0.01% 164
2016
Q3 		– Sell
-5,148
Closed -$381K – 147
2016
Q2 		$381K Buy
+5,148
New +$356K 0.04% 98

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

RNC Capital Management's NVS Position: Q2 2026 in Review

RNC Capital Management reduced its Novartis (NVS) stake by 5.2% in Q2 2026, selling an estimated $35.4K and leaving 4,261 shares worth $668K. The position accounts for 0.03% of the portfolio, ranked #125.

RNC Capital Management first reported a position in NVS in Q2 2016 and has held it in 22 quarters since. The position peaked at $687K in Q1 2026. 1,619 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • RNC Capital Management held 4,261 shares of Novartis worth $668K as of Q2 2026.
  • RNC Capital Management sold 236 Novartis shares in Q2 2026, an estimated $35.4K.
  • Novartis made up 0.03% of RNC Capital Management's portfolio in Q2 2026, its #125 holding.
  • RNC Capital Management first reported a position in Novartis in Q2 2016 and has held it in 22 quarters since.
  • RNC Capital Management's Novartis position peaked at $687K in Q1 2026.
  • 1,619 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on RNC Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.